主动疫苗安全监测指南:国际医学科学组织理事会疫苗安全工作组报告——执行摘要
2013年,国际医学科学组织理事会(CIOMS)成立疫苗安全工作组,针对资源有限国家推出新疫苗或本国新引入疫苗时,制定主动疫苗安全监测(AVSS)指南,帮助国家监管机构和免疫规划官员判断是否需开展非例行药物警戒活动,并提供AVSS类型与实施框架。
要点
- CIOMS疫苗安全工作组制定AVSS指南,首次提供结构化方法识别和分析特定疫苗安全知识缺口。
- 指南面向资源有限国家的国家监管机构和免疫规划官员,用于新疫苗上市或本国新引入疫苗时的决策。
- 指南概述常见AVSS类型及实施考虑,并提供构建有效AVSS的框架。
核心结论
- 指南首次提供结构化方法,在考虑所有可用信息来源的前提下识别和分析特定疫苗安全知识缺口,以判断AVSS是否为合适解决方案。
研究设计与样本
- 2013年,国际医学科学组织理事会(CIOMS)成立疫苗安全工作组,制定主动疫苗安全监测(AVSS)指南。
主要发现
- 指南帮助资源有限国家的国家监管机构和免疫规划官员,在面临新疫苗上市或本国新引入疫苗时,确定非例行药物警戒活动的最佳行动方案。
- 若确认AVSS为合适工具,指南提供AVSS的额外关键信息、常见AVSS类型的详细概述及实际实施考虑。
- 指南提供构建良好且信息丰富的AVSS框架,以在新形势下确保免疫接种的最佳安全性。
临床怎么用
- 国家监管机构和免疫规划官员可在新疫苗上市或本国新引入疫苗时,使用该指南判断是否需要开展非例行药物警戒活动,并在确认AVSS合适时参考其类型与实施框架。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In 2013, the Council for International Organizations of Medical Sciences (CIOMS) created a Working Group on Vaccine Safety (WG) to address unmet needs in the area of vaccine pharmacovigilance. Generating reliable data about specific vaccine safety concerns is becoming a priority due to recent progress in the development and deployment of new vaccines of global importance, as well as novel vaccines targeting diseases specifically endemic to many resource-limited countries (RLCs), e.g. malaria, dengue. The WG created a Guide to Active Vaccine Safety Surveillance (AVSS) to assist national regulatory authorities and national immunization program officers in RLCs in determining the best course of action with regards to non-routine pharmacovigilance activities, when confronted with a launch of a new vaccine or a vaccine that is new to their country. Here we summarize the results of the WG, further detailed in the Guide, which for the first time provides a structured approach to identifying and analyzing specific vaccines safety knowledge gaps, while considering all available sources of information, in order to determine whether AVSS is an appropriate solution. If AVSS is confirmed as being the appropriate tool, the Guide provides additional essential information on AVSS, a detailed overview of common types of AVSS and practical implementation considerations. It also provides a framework for a well-constructed and informative AVSS when needed, thus aiming to ensure the best possible safety of immunization in this new landscape.
引用
- Heininger U, Holm K, Caplanusi I, et al. Guide to active vaccine safety surveillance: Report of CIOMS working group on vaccine safety - executive summary. Vaccine. 2017. PMID: 28645716. doi:10.1016/j.vaccine.2017.06.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。